While galantamine does not provide a significant global benefit for cognitive impairments in schizophrenic patients, it does appear to selectively improve verbal memory and other categories on neuropsychological tests. Reuters Health Information
Results of a post-marketing surveillance study in Japan provide a "real world" picture of the incidence of adverse reactions associated with infliximab therapy for rheumatoid arthritis (RA), according to a Japanese research team. They conclude that the safety profile is acceptable. Reuters Health Information
Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology. Reuters Health Information
Ofatumumab, a new fully human anti-CD20 monoclonal antibody, is well tolerated by patients with chronic lymphocytic leukemia (CLL) in doses up to 2,000 mg. These results of a European-American dose-escalating study support further studies on ofatumumab, according to a report in the February 1 issue of Blood. Reuters Health Information
Atacicept, a recombinant fusion protein that neutralizes the cytokine B lymphocyte stimulator, is well tolerated and shows trends toward clinical improvement in patients with rheumatoid arthritis (RA), according to a report in the January issue of Arthritis & Rheumatism. Reuters Health Information
Voice outcomes are better after chemoradiotherapy (chemo-RT) than after total laryngectomy in patients with advanced laryngopharyngeal cancer, according to a report in the February issue of the International Journal of Radiation Oncology*Biology*Physics. Reuters Health Information
Imatinib mesylate therapy shows lasting safety and efficacy in chronic-phase chronic myeloid leukemia (CML) patients in whom interferon-alpha treatment has failed. Reuters Health Information
Treatment with statins appears to reduce the risk of renal cell carcinoma, according to the results of a case-control study of nearly 500,000 veterans. Reuters Health Information
Aripiprazole, an atypical antipsychotic, was both effective and well tolerated in an open-label trial involving adults aged 50 and older with bipolar disorder, according to a report in the January issue of the Journal of Clinical Psychiatry. Reuters Health Information
